Thread by nickcarraway.
Many surprised by event billed as diversity presentation
Alveda King speaks about abortion Tuesday in Warriner
Some students at Alveda King's speech Tuesday night did not expect a strictly literal interpretation of the advertised "life affirming choices" speech.
The niece of Dr. Martin Luther King spoke out strongly against abortion at her "Can the Dream Survive?" presentation in Warriner Hall's Plachta Auditorium. Some students were surprised to learn that was the topic of her lecture. Several of the about 650-person audience walked out.
"I felt a little misled personally," said Flint senior Detrone Turner, who said he thought the speech was going to be about increasing diversity.
Sponsored by The Student Budget Allocation Committee, The Office for Institutional Diversity and Students For Life, King presented a PowerPoint called "Can the Dream Survive If the Kids Are Dead?"
. . .
Threads by GonzoII, Salvation and me.
WASHINGTON (CNN) -- President Obama signed an executive order Monday repealing a Bush-era policy that limited federal tax dollars for embryonic stem cell research.
Obama's move overturns an order signed by President Bush in 2001 that barred the National Institutes of Health from funding research on embryonic stem cells beyond using 60 cell lines that existed at that time. . .
Salem, OR - March 9, 2009 - “President Obama’s decision to lift the ban on using taxpayer dollars for embryonic stem cell research is deadly for human lives and completely unnecessary”, said Gayle Atteberry, Executive Director of Oregon Right to Life.
“Ten years of research with embryonic stem cells has produced nothing but failure after failure, while research with adult stem cells and reprogrammed cells is finding cures and clinical successes on a regular basis,” Ms. Atteberry continued. . .
Washington, DC (LifeNews.com) -- President Barack Obama may win applause from some in the scientific community for his expected decision on Monday to overturn President Bush's limits on embryonic stem cell research funding. But some scientists say the controversial research is no longer the hot prospect for patients.
Bernadine Healy, the former head of the National institutes of Health and the American Red Cross says the remarkable advances of induced pluripotent stem cells (iPS cells) are beginning to subsume embryonic stem cells.
She wrote in U.S News and World Report that IPSC and adult stem cell research successes have "diminished" the prospect that ESCR is the future of regenerative medicine.
"Even for strong backers of embryonic stem cell research, [Obama's decision] is no longer as self-evident as it was, because there is markedly diminished need for expanding these cell lines for either patient therapy or basic research," Healy explains. . .